nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—osteoarthritis—Prednisone—Crohn's disease	0.195	1	CpDpCtD
Tolmetin—CXCL8—Crohn's disease	0.127	0.483	CbGaD
Tolmetin—MPO—Crohn's disease	0.099	0.376	CbGaD
Tolmetin—Aminohippurate—Balsalazide—Crohn's disease	0.0961	0.385	CrCrCtD
Tolmetin—Bromfenac—Balsalazide—Crohn's disease	0.0961	0.385	CrCrCtD
Tolmetin—MPO—Mesalazine—Crohn's disease	0.0856	0.358	CbGbCtD
Tolmetin—Fenbufen—Balsalazide—Crohn's disease	0.0575	0.23	CrCrCtD
Tolmetin—PTGS2—Crohn's disease	0.0371	0.141	CbGaD
Tolmetin—PTGS2—Balsalazide—Crohn's disease	0.037	0.155	CbGbCtD
Tolmetin—PTGS1—Balsalazide—Crohn's disease	0.0312	0.131	CbGbCtD
Tolmetin—PTGS2—Mesalazine—Crohn's disease	0.0296	0.124	CbGbCtD
Tolmetin—PTGS1—Mesalazine—Crohn's disease	0.025	0.105	CbGbCtD
Tolmetin—PTGS2—Sulfasalazine—Crohn's disease	0.0165	0.0692	CbGbCtD
Tolmetin—PTGS1—Sulfasalazine—Crohn's disease	0.014	0.0584	CbGbCtD
Tolmetin—MPO—superior mesenteric artery—Crohn's disease	0.0124	0.64	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—Crohn's disease	0.000827	0.0427	CbGeAlD
Tolmetin—TDO2—lymph node—Crohn's disease	0.000677	0.035	CbGeAlD
Tolmetin—MPO—epithelium—Crohn's disease	0.000502	0.0259	CbGeAlD
Tolmetin—MPO—skin of body—Crohn's disease	0.000477	0.0247	CbGeAlD
Tolmetin—PTGS2—gall bladder—Crohn's disease	0.00044	0.0227	CbGeAlD
Tolmetin—PTGS2—mouth—Crohn's disease	0.000391	0.0202	CbGeAlD
Tolmetin—MPO—lymphoid tissue—Crohn's disease	0.000387	0.02	CbGeAlD
Tolmetin—MPO—digestive system—Crohn's disease	0.000382	0.0197	CbGeAlD
Tolmetin—CXCL8—lymph node—Crohn's disease	0.000373	0.0193	CbGeAlD
Tolmetin—Aminohippurate—SLC22A4—Crohn's disease	0.000298	0.194	CrCbGaD
Tolmetin—PTGS1—epithelium—Crohn's disease	0.000238	0.0123	CbGeAlD
Tolmetin—PTGS1—smooth muscle tissue—Crohn's disease	0.000229	0.0119	CbGeAlD
Tolmetin—PTGS2—epithelium—Crohn's disease	0.000228	0.0118	CbGeAlD
Tolmetin—PTGS1—skin of body—Crohn's disease	0.000226	0.0117	CbGeAlD
Tolmetin—Aminohippurate—SLC22A5—Crohn's disease	0.000224	0.146	CrCbGaD
Tolmetin—PTGS2—smooth muscle tissue—Crohn's disease	0.000219	0.0113	CbGeAlD
Tolmetin—Indomethacin—CXCL8—Crohn's disease	0.000219	0.143	CrCbGaD
Tolmetin—MPO—lymph node—Crohn's disease	0.000218	0.0113	CbGeAlD
Tolmetin—PTGS2—skin of body—Crohn's disease	0.000216	0.0112	CbGeAlD
Tolmetin—PTGS1—mammalian vulva—Crohn's disease	0.000207	0.0107	CbGeAlD
Tolmetin—PTGS1—digestive system—Crohn's disease	0.000181	0.00936	CbGeAlD
Tolmetin—PTGS2—lymphoid tissue—Crohn's disease	0.000175	0.00906	CbGeAlD
Tolmetin—PTGS2—digestive system—Crohn's disease	0.000173	0.00895	CbGeAlD
Tolmetin—Ketorolac—PTGS2—Crohn's disease	0.000163	0.106	CrCbGaD
Tolmetin—Bromfenac—PTGS2—Crohn's disease	0.000156	0.102	CrCbGaD
Tolmetin—Proteinuria—Mesalazine—Crohn's disease	0.000137	0.0365	CcSEcCtD
Tolmetin—Protein urine present—Mesalazine—Crohn's disease	0.000135	0.036	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—Crohn's disease	0.000133	0.0864	CrCbGaD
Tolmetin—Stomatitis—Mercaptopurine—Crohn's disease	0.000121	0.0322	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—Crohn's disease	0.000121	0.0786	CrCbGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.000115	0.00402	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL12B—Crohn's disease	0.000114	0.00399	CbGpPWpGaD
Tolmetin—Blood urea increased—Mesalazine—Crohn's disease	0.000114	0.0303	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—Crohn's disease	0.000113	0.00394	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—STAT3—Crohn's disease	0.000111	0.00389	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—UBE2D1—Crohn's disease	0.00011	0.00383	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR9—Crohn's disease	0.00011	0.00383	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000109	0.0038	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—CRP—Crohn's disease	0.000106	0.00372	CbGpPWpGaD
Tolmetin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000106	0.0037	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—Crohn's disease	0.000105	0.00365	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL3—Crohn's disease	0.000104	0.00362	CbGpPWpGaD
Tolmetin—PTGS1—lymph node—Crohn's disease	0.000103	0.00535	CbGeAlD
Tolmetin—MPO—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.000103	0.00359	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—ALB—Crohn's disease	0.000103	0.00359	CbGpPWpGaD
Tolmetin—Lymphadenopathy—Mesalazine—Crohn's disease	0.000103	0.0273	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL10—Crohn's disease	0.000102	0.00358	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—ACKR2—Crohn's disease	0.000101	0.00353	CbGpPWpGaD
Tolmetin—Suprofen—PTGS2—Crohn's disease	0.0001	0.0655	CrCbGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TAB1—Crohn's disease	0.0001	0.00351	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	9.96e-05	0.00348	CbGpPWpGaD
Tolmetin—PTGS2—lymph node—Crohn's disease	9.89e-05	0.00511	CbGeAlD
Tolmetin—CXCL8—Overview of nanoparticle effects—IL6—Crohn's disease	9.83e-05	0.00343	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ICAM1—Crohn's disease	9.78e-05	0.00342	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	9.66e-05	0.00337	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—TNF—Crohn's disease	9.64e-05	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—MLN—Crohn's disease	9.57e-05	0.00335	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IFNG—Crohn's disease	9.37e-05	0.00327	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—JAK2—Crohn's disease	9.29e-05	0.00325	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2RA—Crohn's disease	9.12e-05	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL18—Crohn's disease	9.1e-05	0.00318	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—JAK2—Crohn's disease	8.99e-05	0.00314	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	8.91e-05	0.00311	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	8.91e-05	0.00311	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—SBSPON—Crohn's disease	8.89e-05	0.00311	CbGpPWpGaD
Tolmetin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	8.76e-05	0.0233	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	8.71e-05	0.00305	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	8.68e-05	0.00303	CbGpPWpGaD
Tolmetin—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	8.66e-05	0.023	CcSEcCtD
Tolmetin—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	8.62e-05	0.00301	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR6—Crohn's disease	8.61e-05	0.00301	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL1B—Crohn's disease	8.36e-05	0.00292	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Crohn's disease	8.32e-05	0.00291	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	8.28e-05	0.00289	CbGpPWpGaD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	8.26e-05	0.00289	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	8.23e-05	0.00287	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ALB—Crohn's disease	8.16e-05	0.00285	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PLA2G4F—Crohn's disease	8.15e-05	0.00285	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	8.1e-05	0.00283	CbGpPWpGaD
Tolmetin—Abdominal discomfort—Azathioprine—Crohn's disease	7.97e-05	0.0212	CcSEcCtD
Tolmetin—Oedema—Mercaptopurine—Crohn's disease	7.93e-05	0.0211	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—SMAD3—Crohn's disease	7.85e-05	0.00274	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	7.84e-05	0.00274	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL6—Crohn's disease	7.78e-05	0.00272	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Mercaptopurine—Crohn's disease	7.76e-05	0.0206	CcSEcCtD
Tolmetin—Gastritis—Mesalazine—Crohn's disease	7.75e-05	0.0206	CcSEcCtD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.73e-05	0.0027	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.73e-05	0.0027	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	7.68e-05	0.00268	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	7.67e-05	0.00268	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—Crohn's disease	7.6e-05	0.00266	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CD4—Crohn's disease	7.46e-05	0.00261	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—Crohn's disease	7.45e-05	0.0026	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—Crohn's disease	7.44e-05	0.0026	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—Crohn's disease	7.41e-05	0.00259	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TLR4—Crohn's disease	7.3e-05	0.00255	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	7.26e-05	0.00254	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR6—Crohn's disease	7.26e-05	0.00254	CbGpPWpGaD
Tolmetin—Abdominal discomfort—Mesalazine—Crohn's disease	7.26e-05	0.0193	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—Crohn's disease	7.14e-05	0.00249	CbGpPWpGaD
Tolmetin—Dysuria—Mesalazine—Crohn's disease	7.08e-05	0.0188	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	6.95e-05	0.00243	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—UBE2D1—Crohn's disease	6.94e-05	0.00243	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MTMR3—Crohn's disease	6.93e-05	0.00242	CbGpPWpGaD
Tolmetin—Agranulocytosis—Azathioprine—Crohn's disease	6.91e-05	0.0184	CcSEcCtD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	6.91e-05	0.00241	CbGpPWpGaD
Tolmetin—Weight increased—Mesalazine—Crohn's disease	6.89e-05	0.0183	CcSEcCtD
Tolmetin—Weight decreased—Mesalazine—Crohn's disease	6.85e-05	0.0182	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	6.82e-05	0.00238	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—STAT3—Crohn's disease	6.82e-05	0.00238	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	6.73e-05	0.00235	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	6.72e-05	0.00235	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL1B—Crohn's disease	6.64e-05	0.00232	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR9—Crohn's disease	6.64e-05	0.00232	CbGpPWpGaD
Tolmetin—Renal failure—Mesalazine—Crohn's disease	6.63e-05	0.0176	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—Crohn's disease	6.63e-05	0.00232	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—STAT3—Crohn's disease	6.6e-05	0.0023	CbGpPWpGaD
Tolmetin—Stomatitis—Mesalazine—Crohn's disease	6.58e-05	0.0175	CcSEcCtD
Tolmetin—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	6.57e-05	0.0023	CbGpPWpGaD
Tolmetin—Urinary tract infection—Mesalazine—Crohn's disease	6.56e-05	0.0174	CcSEcCtD
Tolmetin—Haematuria—Mesalazine—Crohn's disease	6.43e-05	0.0171	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—Crohn's disease	6.39e-05	0.0417	CrCbGaD
Tolmetin—Epistaxis—Mesalazine—Crohn's disease	6.37e-05	0.0169	CcSEcCtD
Tolmetin—Agranulocytosis—Mesalazine—Crohn's disease	6.3e-05	0.0167	CcSEcCtD
Tolmetin—Erythema multiforme—Azathioprine—Crohn's disease	6.29e-05	0.0167	CcSEcCtD
Tolmetin—Body temperature increased—Mercaptopurine—Crohn's disease	6.27e-05	0.0167	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—GPR65—Crohn's disease	6.17e-05	0.00216	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—Crohn's disease	6.07e-05	0.00212	CbGpPWpGaD
Tolmetin—Hepatitis—Mesalazine—Crohn's disease	6.06e-05	0.0161	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IFNG—Crohn's disease	6.02e-05	0.0021	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—Crohn's disease	6.02e-05	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TLR4—Crohn's disease	5.99e-05	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RBX1—Crohn's disease	5.98e-05	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—HSPA1B—Crohn's disease	5.98e-05	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—Crohn's disease	5.94e-05	0.00208	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	5.88e-05	0.00205	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	5.84e-05	0.00204	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	5.77e-05	0.00202	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—Crohn's disease	5.77e-05	0.00202	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	5.76e-05	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—ICAM1—Crohn's disease	5.74e-05	0.002	CbGpPWpGaD
Tolmetin—Erythema multiforme—Mesalazine—Crohn's disease	5.73e-05	0.0152	CcSEcCtD
Tolmetin—Indomethacin—ALB—Crohn's disease	5.69e-05	0.0371	CrCbGaD
Tolmetin—Tinnitus—Mesalazine—Crohn's disease	5.65e-05	0.015	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	5.62e-05	0.00196	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.45e-05	0.0019	CbGpPWpGaD
Tolmetin—Diarrhoea—Mercaptopurine—Crohn's disease	5.43e-05	0.0144	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	5.42e-05	0.0019	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—MLN—Crohn's disease	5.41e-05	0.00189	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—FADS1—Crohn's disease	5.4e-05	0.00189	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1B—Crohn's disease	5.37e-05	0.00188	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	5.34e-05	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	5.25e-05	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—UBE2D1—Crohn's disease	5.25e-05	0.00183	CbGpPWpGaD
Tolmetin—Flatulence—Mesalazine—Crohn's disease	5.2e-05	0.0138	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—ACKR2—Crohn's disease	5.18e-05	0.00181	CbGpPWpGaD
Tolmetin—Vascular purpura—Prednisone—Crohn's disease	5.18e-05	0.0138	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	5.14e-05	0.0018	CbGpPWpGaD
Tolmetin—Cardiac failure congestive—Prednisone—Crohn's disease	5.11e-05	0.0136	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	5.08e-05	0.00178	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GPX4—Crohn's disease	5.05e-05	0.00177	CbGpPWpGaD
Tolmetin—Vomiting—Mercaptopurine—Crohn's disease	5.04e-05	0.0134	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—MLN—Crohn's disease	4.91e-05	0.00172	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—Crohn's disease	4.89e-05	0.00171	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GCKR—Crohn's disease	4.88e-05	0.00171	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—Crohn's disease	4.82e-05	0.00168	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.82e-05	0.00168	CbGpPWpGaD
Tolmetin—Purpura—Prednisone—Crohn's disease	4.81e-05	0.0128	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—Crohn's disease	4.79e-05	0.00167	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—Crohn's disease	4.76e-05	0.00166	CbGpPWpGaD
Tolmetin—Nausea—Mercaptopurine—Crohn's disease	4.71e-05	0.0125	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	4.63e-05	0.0123	CcSEcCtD
Tolmetin—Thrombocytopenia—Azathioprine—Crohn's disease	4.63e-05	0.0123	CcSEcCtD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.59e-05	0.0016	CbGpPWpGaD
Tolmetin—Chest pain—Mesalazine—Crohn's disease	4.49e-05	0.0119	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCR6—Crohn's disease	4.4e-05	0.00154	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	4.38e-05	0.00153	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—Crohn's disease	4.37e-05	0.00153	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	4.36e-05	0.00152	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	4.31e-05	0.0015	CbGpPWpGaD
Tolmetin—Oedema—Mesalazine—Crohn's disease	4.3e-05	0.0114	CcSEcCtD
Tolmetin—Anaphylactic shock—Mesalazine—Crohn's disease	4.3e-05	0.0114	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—Crohn's disease	4.28e-05	0.00149	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Mesalazine—Crohn's disease	4.21e-05	0.0112	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—Crohn's disease	4.19e-05	0.00146	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	4e-05	0.0014	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—Crohn's disease	3.97e-05	0.00139	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.93e-05	0.00137	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.93e-05	0.00137	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.93e-05	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—Crohn's disease	3.9e-05	0.00136	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—Crohn's disease	3.89e-05	0.00136	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—Crohn's disease	3.89e-05	0.00136	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTGER4—Crohn's disease	3.87e-05	0.00135	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Azathioprine—Crohn's disease	3.86e-05	0.0103	CcSEcCtD
Tolmetin—Somnolence—Mesalazine—Crohn's disease	3.83e-05	0.0102	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	3.8e-05	0.00133	CbGpPWpGaD
Tolmetin—Dyspepsia—Mesalazine—Crohn's disease	3.79e-05	0.0101	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—CCR9—Crohn's disease	3.75e-05	0.00131	CbGpPWpGaD
Tolmetin—Abdominal pain—Azathioprine—Crohn's disease	3.74e-05	0.00993	CcSEcCtD
Tolmetin—Body temperature increased—Azathioprine—Crohn's disease	3.74e-05	0.00993	CcSEcCtD
Tolmetin—Constipation—Mesalazine—Crohn's disease	3.68e-05	0.00979	CcSEcCtD
Tolmetin—Weight increased—Prednisone—Crohn's disease	3.64e-05	0.00969	CcSEcCtD
Tolmetin—Weight decreased—Prednisone—Crohn's disease	3.62e-05	0.00963	CcSEcCtD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—STAT3—Crohn's disease	3.58e-05	0.00125	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	3.53e-05	0.00124	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Mesalazine—Crohn's disease	3.52e-05	0.00936	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—GPR65—Crohn's disease	3.49e-05	0.00122	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—Crohn's disease	3.46e-05	0.00121	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	3.46e-05	0.00121	CbGpPWpGaD
Tolmetin—Urticaria—Mesalazine—Crohn's disease	3.42e-05	0.00909	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	3.42e-05	0.00119	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR9—Crohn's disease	3.41e-05	0.00119	CbGpPWpGaD
Tolmetin—Body temperature increased—Mesalazine—Crohn's disease	3.4e-05	0.00905	CcSEcCtD
Tolmetin—Abdominal pain—Mesalazine—Crohn's disease	3.4e-05	0.00905	CcSEcCtD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.34e-05	0.00117	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	3.34e-05	0.00117	CbGpPWpGaD
Tolmetin—Diarrhoea—Azathioprine—Crohn's disease	3.23e-05	0.0086	CcSEcCtD
Tolmetin—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.18e-05	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	3.18e-05	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GPR65—Crohn's disease	3.17e-05	0.00111	CbGpPWpGaD
Tolmetin—Dizziness—Azathioprine—Crohn's disease	3.12e-05	0.00831	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.12e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.12e-05	0.00109	CbGpPWpGaD
Tolmetin—Asthenia—Mesalazine—Crohn's disease	3.09e-05	0.00821	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—ACKR2—Crohn's disease	3.06e-05	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	3.05e-05	0.00107	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	3.05e-05	0.00106	CbGpPWpGaD
Tolmetin—Vomiting—Azathioprine—Crohn's disease	3e-05	0.00799	CcSEcCtD
Tolmetin—Headache—Azathioprine—Crohn's disease	2.96e-05	0.00787	CcSEcCtD
Tolmetin—Diarrhoea—Mesalazine—Crohn's disease	2.94e-05	0.00783	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.92e-05	0.00102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MLN—Crohn's disease	2.9e-05	0.00101	CbGpPWpGaD
Tolmetin—Dizziness—Mesalazine—Crohn's disease	2.85e-05	0.00757	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—Crohn's disease	2.83e-05	0.000987	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.82e-05	0.000984	CbGpPWpGaD
Tolmetin—Nausea—Azathioprine—Crohn's disease	2.81e-05	0.00746	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.77e-05	0.000967	CbGpPWpGaD
Tolmetin—Vomiting—Mesalazine—Crohn's disease	2.74e-05	0.00728	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	2.72e-05	0.00095	CbGpPWpGaD
Tolmetin—Headache—Mesalazine—Crohn's disease	2.7e-05	0.00717	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.66e-05	0.000928	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TAGAP—Crohn's disease	2.65e-05	0.000928	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	2.65e-05	0.000926	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.63e-05	0.000919	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	2.62e-05	0.000916	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.61e-05	0.00091	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	2.56e-05	0.000895	CbGpPWpGaD
Tolmetin—Nausea—Mesalazine—Crohn's disease	2.56e-05	0.0068	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	2.51e-05	0.000878	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—Crohn's disease	2.5e-05	0.000875	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—Crohn's disease	2.5e-05	0.000875	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR6—Crohn's disease	2.48e-05	0.000868	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	2.48e-05	0.000866	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	2.46e-05	0.00086	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.45e-05	0.000855	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.44e-05	0.000853	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	2.42e-05	0.000847	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	2.42e-05	0.000845	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RSPO3—Crohn's disease	2.32e-05	0.000811	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—Crohn's disease	2.28e-05	0.000797	CbGpPWpGaD
Tolmetin—Oedema—Prednisone—Crohn's disease	2.28e-05	0.00605	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisone—Crohn's disease	2.28e-05	0.00605	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—STAT3—Crohn's disease	2.27e-05	0.000793	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.26e-05	0.00079	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR6—Crohn's disease	2.26e-05	0.000788	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SEL1L—Crohn's disease	2.2e-05	0.000769	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTGER4—Crohn's disease	2.19e-05	0.000764	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	2.16e-05	0.000754	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.07e-05	0.000723	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR9—Crohn's disease	2.01e-05	0.000703	CbGpPWpGaD
Tolmetin—Dyspepsia—Prednisone—Crohn's disease	2e-05	0.00533	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	2e-05	0.000699	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTGER4—Crohn's disease	1.99e-05	0.000694	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.97e-05	0.000689	CbGpPWpGaD
Tolmetin—Constipation—Prednisone—Crohn's disease	1.95e-05	0.00518	CcSEcCtD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.94e-05	0.000677	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.91e-05	0.000668	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GPR65—Crohn's disease	1.87e-05	0.000654	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL3—Crohn's disease	1.86e-05	0.000651	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Prednisone—Crohn's disease	1.86e-05	0.00495	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.82e-05	0.000637	CbGpPWpGaD
Tolmetin—Urticaria—Prednisone—Crohn's disease	1.81e-05	0.00481	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—RASGRP1—Crohn's disease	1.8e-05	0.00063	CbGpPWpGaD
Tolmetin—Body temperature increased—Prednisone—Crohn's disease	1.8e-05	0.00479	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—Crohn's disease	1.8e-05	0.00479	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.78e-05	0.000621	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.75e-05	0.000612	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.73e-05	0.000606	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—Crohn's disease	1.71e-05	0.000599	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.71e-05	0.000596	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL3—Crohn's disease	1.69e-05	0.000591	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RASGRP1—Crohn's disease	1.64e-05	0.000572	CbGpPWpGaD
Tolmetin—Asthenia—Prednisone—Crohn's disease	1.63e-05	0.00434	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.59e-05	0.000556	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—Crohn's disease	1.58e-05	0.000554	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.57e-05	0.000547	CbGpPWpGaD
Tolmetin—Diarrhoea—Prednisone—Crohn's disease	1.56e-05	0.00414	CcSEcCtD
Tolmetin—TDO2—Metabolism—ALB—Crohn's disease	1.55e-05	0.000543	CbGpPWpGaD
Tolmetin—Dizziness—Prednisone—Crohn's disease	1.51e-05	0.004	CcSEcCtD
Tolmetin—PTGS1—Metabolism—MTMR3—Crohn's disease	1.49e-05	0.00052	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RSPO3—Crohn's disease	1.45e-05	0.000507	CbGpPWpGaD
Tolmetin—Vomiting—Prednisone—Crohn's disease	1.45e-05	0.00385	CcSEcCtD
Tolmetin—Headache—Prednisone—Crohn's disease	1.43e-05	0.00379	CcSEcCtD
Tolmetin—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.39e-05	0.000486	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SEL1L—Crohn's disease	1.38e-05	0.000481	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—Crohn's disease	1.36e-05	0.000475	CbGpPWpGaD
Tolmetin—Nausea—Prednisone—Crohn's disease	1.35e-05	0.0036	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—CCR6—Crohn's disease	1.33e-05	0.000466	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2RA—Crohn's disease	1.31e-05	0.000456	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.26e-05	0.000441	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.24e-05	0.000433	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LTF—Crohn's disease	1.23e-05	0.000431	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RBX1—Crohn's disease	1.21e-05	0.000421	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—Crohn's disease	1.2e-05	0.000418	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2RA—Crohn's disease	1.19e-05	0.000414	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTMR3—Crohn's disease	1.18e-05	0.000413	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTGER4—Crohn's disease	1.17e-05	0.00041	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FADS1—Crohn's disease	1.16e-05	0.000405	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX4—Crohn's disease	1.09e-05	0.00038	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—UBE2D1—Crohn's disease	1.06e-05	0.000369	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCKR—Crohn's disease	1.05e-05	0.000367	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RIPK2—Crohn's disease	1.02e-05	0.000358	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL3—Crohn's disease	9.99e-06	0.000349	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	9.99e-06	0.000349	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GCKR—Crohn's disease	9.95e-06	0.000348	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RASGRP1—Crohn's disease	9.67e-06	0.000338	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FADS1—Crohn's disease	9.21e-06	0.000322	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	8.81e-06	0.000308	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC11A1—Crohn's disease	8.79e-06	0.000307	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—JAK2—Crohn's disease	8.77e-06	0.000306	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SOCS1—Crohn's disease	8.76e-06	0.000306	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX4—Crohn's disease	8.63e-06	0.000301	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	8.42e-06	0.000294	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TYK2—Crohn's disease	8.35e-06	0.000292	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCKR—Crohn's disease	8.33e-06	0.000291	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—JAK2—Crohn's disease	7.97e-06	0.000278	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD3—Crohn's disease	7.56e-06	0.000264	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RBX1—Crohn's disease	7.54e-06	0.000263	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSPA1B—Crohn's disease	7.54e-06	0.000263	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.5e-06	0.000262	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2RA—Crohn's disease	7e-06	0.000245	CbGpPWpGaD
Tolmetin—PTGS2—Disease—UBE2D1—Crohn's disease	6.61e-06	0.000231	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.56e-06	0.000229	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.95e-06	0.000208	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TYK2—Crohn's disease	4.93e-06	0.000172	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD3—Crohn's disease	4.73e-06	0.000165	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAK2—Crohn's disease	4.71e-06	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—Crohn's disease	4.08e-06	0.000143	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—Crohn's disease	3.45e-06	0.000121	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—Crohn's disease	3.34e-06	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TYK2—Crohn's disease	3.09e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAK2—Crohn's disease	2.94e-06	0.000103	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—Crohn's disease	2.92e-06	0.000102	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—Crohn's disease	2.79e-06	9.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—Crohn's disease	2.65e-06	9.26e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—Crohn's disease	2.41e-06	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—Crohn's disease	2.16e-06	7.55e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—Crohn's disease	1.51e-06	5.27e-05	CbGpPWpGaD
